A 20-minute infusion of PACAP induced delayed migraine attacks in migraine patients 4-5 hours after the termination of the infusion (Schytz et al., 2009) while two hours of continuous VIP infusion was necessary to generate migraine attacks (Pellesi et al., 2021). Here, ADCYAP1 is linked to migraine disorder.